Prulifloxacin, gatifloxacin is oral fluoroquinolone antibiotics. After the absorption, the prodrug active metabolites through. The drug has the elimination half-life, to allow once-daily dosing. You Lisha star is usually more active than other fluoroquinolones in vitro a variety of clinical isolates of Gram-negative bacteria, including community and hospital C OLI suppressed by the pathogenic strains of Haemophilus influenzae 90%, deformation cloacae, Providencia Providencia neighborhood island and suppress Serratia, catarrhal Haemophilus Moraxella for You Lisha star activity against Pseudomonas aeruginosa vary by country. Gram-positive organisms such as methicillin or oxacillin including MSSA Enterococcus (Enterococcusspp.) And Streptococcus pneumoniae Italian immigrant communities vulnerable ulifloxac. Spain active strains moderate pneumonia. In well-designed clinical trials, as well as good clinical, bacteriological efficacy (similar to ciprofloxacin, amoxicillin or significantly Pefloxacin <50kg600 prulifloxacin 10 days with acute exacerbation of chronic bronchitis or complex under Urinary tract infections (UTIs), a single dose of 600mg acute prulifloxacin, not complicated at UT. two kinds Prulifloxacin clinical trials are usually well tolerated, signings also possible ciprofloxacin resistance.
没有评论:
发表评论